Hutchmed (China) Limited
Biopharmaceutical firm developing targeted therapies for cancer and immune diseases.
HCM | HKEX
Overview
Corporate Details
- ISIN(s):
- KYG4672N1198 (+1 more)
- LEI:
- 2138006X34YDQ6OBYE79
- Country:
- Hong Kong
- Address:
- LEVEL 18, THE METROPOLIS TOWER, KOWLOON
- Website:
- https://www.hutch-med.com/
- Sector:
- Manufacturing
Description
Hutchmed is a commercial-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapeutics and immunotherapies. The company operates a fully integrated platform, advancing a pipeline of novel drug candidates for the treatment of cancer and immunological diseases. Its research and development strategy focuses on creating highly selective and potent therapies engineered to improve drug exposure and reduce off-target toxicities. Hutchmed has multiple internally discovered medicines approved and marketed for various oncology and immunology indications, supported by a global commercialization infrastructure.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-06-29 09:00 |
Start of Savolitinib Global PRCC Phase III Trial
|
English | 29.6 KB | ||
| 2017-06-29 09:00 |
Chi-Med to Announce 2017 HY Financial Results
|
English | 18.4 KB | ||
| 2017-06-22 09:00 |
Chi-Med starts Ph I/II Trial of HMPL 453 in China
|
English | 27.2 KB | ||
| 2017-06-16 11:57 |
Director's Share Dealing
|
English | 73.0 KB | ||
| 2017-06-12 09:00 |
Fruquintinib NDA for Advanced CRC Filed with CFDA
|
English | 23.4 KB | ||
| 2017-06-06 09:00 |
Phase III Fruquintinib Data presented at ASCO
|
English | 27.5 KB | ||
| 2017-05-18 09:00 |
Chi-Med Presents Clinical Data at ASCO 2017
|
English | 42.5 KB | ||
| 2017-04-28 15:40 |
Total Voting Rights
|
English | 19.8 KB | ||
| 2017-04-27 16:10 |
Results of Annual General Meeting
|
English | 38.7 KB | ||
| 2017-04-07 09:00 |
Pre-clinical Data Presented at AACR
|
English | 36.9 KB | ||
| 2017-03-31 09:00 |
Total Voting Rights
|
English | 19.8 KB | ||
| 2017-03-29 10:07 |
Vesting of LTIP awards
|
English | 51.8 KB | ||
| 2017-03-28 13:00 |
Grant of Share Options under Share Option Scheme
|
English | 38.9 KB | ||
| 2017-03-27 09:00 |
2016 Annual Report and Notice of AGM
|
English | 19.8 KB | ||
| 2017-03-24 08:00 |
Appointment of Director
|
English | 25.8 KB |
Automate Your Workflow. Get a real-time feed of all Hutchmed (China) Limited filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hutchmed (China) Limited
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hutchmed (China) Limited via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
